Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jeff S. Flick"'
Autor:
Ilia Ichetovkin, Tracey C. Fleischer, Larry Cousins, Ashoka D. Polpitiya, M. Sean Esplin, J. Jay Boniface, Dean V. Coonrod, Trina Pugmire, Chad Bradford, Glenn Markenson, Chien Hsu, Andrew D. Gassman, Max T. Dufford, Leonardo Pereira, Kim A. Boggess, Jeff S. Flick, Scott Sullivan, Jay D. Iams, Rob Severinsen, Angela C. Fox, Garrett K. Lam, Matthew K. Hoffman, George R. Saade, Durlin E. Hickok, Paul Kearney
Publikováno v:
American Journal of Obstetrics and Gynecology. 214:S148-S149
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cd7faa5f3dbbdc21e055b62cb660882
https://doi.org/10.1016/j.ajog.2015.10.291
https://doi.org/10.1016/j.ajog.2015.10.291
Autor:
Max T. Dufford, Jeff S. Flick, Ilia Ichetovkin, Ashoka D. Polpitiya, Robert D. Severinsen, Tracey C. Fleischer, J. Jay Boniface, Trina Pugmire, Durlin E. Hickok, Chad Bradford
Publikováno v:
American Journal of Clinical Pathology. 144:A065-A065
Introduction: Preterm birth (PTB), a condition with complex etiological factors, is the leading cause of neonatal mortality and morbidity. Existing tests have poor performance, especially for nulliparous women. There is a compelling need to identify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6f6e2594abf5d098028e1fafddb9f4c
https://doi.org/10.1093/ajcp/144.suppl2.065
https://doi.org/10.1093/ajcp/144.suppl2.065
Autor:
Damon I. Papac, Ryan T. Terry-Lorenzo, Vijay Baichwal, Jeff S. Flick, Tracey C. Fleischer, Andrew D. Gassman, J. Jay Boniface, Ashley Peterson, Lynn DeMie, Jeremy P. Green, Robert O. Carlson, Rosann Robinson, Daniel M. Cimbora, Siavash Ghaffari
Publikováno v:
Cancer Research. 71:577-577
Background: MPC-9528 is a potent and selective inhibitor of the NAD biosynthetic enzyme nicotinamide phosphoribosyltransferase (Nampt). Inhibition of Nampt by MPC-9528 causes depletion of cellular NAD followed by a decrease in ATP and cell death. Can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e11d2dcf73c9518e51ab6eb7d198568d
https://doi.org/10.1158/1538-7445.am2011-577
https://doi.org/10.1158/1538-7445.am2011-577
Autor:
J. Jay Boniface, Tracey C. Fleischer, Ryan T. Terry-Lorenzo, Jeff S. Flick, Brett Murphy, Zhong-hua Gao, J Adam Willardson
Publikováno v:
Cancer Research. 70:3673-3673
Background: Drug discovery based on cellular phenotypes is impeded by the challenge of identifying the molecular target. To alleviate this problem, Myriad Pharmaceuticals has developed a chemical proteomics process to identify cellular proteins that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2a89b221b41bb9f21fab3416efc1b58
https://doi.org/10.1158/1538-7445.am10-3673
https://doi.org/10.1158/1538-7445.am10-3673